Community-acquired pneumonia: Difference between revisions

Pneumonia Main Page
	Community-Acquired Pneumonia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Community-acquired pneumonia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Severity Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
Ultrasound
Other Diagnostic Studies
Treatment
Hospital Admission Decision
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Community-acquired pneumonia On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Community-acquired pneumonia All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Community-acquired pneumonia
CDC on Community-acquired pneumonia
Community-acquired pneumonia in the news
Blogs on Community-acquired pneumonia
Directions to Hospitals Treating Community-acquired pneumonia
Risk calculators and risk factors for Community-acquired pneumonia

VisualWikitext

Latest revision as of 17:25, 30 November 2020

For the main page on pneumonia, click here.

For hospital-acquired pneumonia, click here.

For patient information on pneumonia, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]; Nazma Hanif, MD [3]

Assistant Editor-In-Chief: Simran Singh

Synonyms and keywords: CAP

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Community-acquired pneumonia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

Medical Therapy | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

@@ Line 1: / Line 1: @@
-{{Pneumonia}}
+__NOTOC__
-{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh@perfuse.org]; [[Philip Marcus, M.D., M.P.H.]][mailto:pmarcus192@aol.com]
+{| class="infobox" style="float:right;"
+|-
+|[[File:Siren.gif|30px|link=Community acquired pneumonia resident survival guide]]||<br>||<br>
+|[[Community acquired pneumonia resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
+|}
+{{Community-acquired pneumonia|classification=Classification}}
-==[[Pneumonia overview|Overview]]==
+'''For the main page on pneumonia, click [[pneumonia|here]].'''
-==[[Pneumonia pathophysiology|Pathophysiology]]==
+'''For hospital-acquired pneumonia, click [[hospital-acquired pneumonia|here]].'''
-==[[Pneumonia epidemiology and demographics|Epidemiology & Demographics]]==
+'''For patient information on pneumonia, click [[Pneumonia (patient information)|here]].'''
-==[[Pneumonia risk factors|Risk Factors]]==
+{{CMG}}; {{AE}} {{AL}}; {{NH}}
+ '''Assistant Editor-In-Chief:''' Simran Singh
-==[[Pneumonia natural history, complications, and prognosis|Natural History, Complications & Prognosis]]==
+{{SK}} CAP
-==[[Pneumonia causes|Causes of Pneumonia]]==
+==[[Community-acquired pneumonia overview|Overview]]==
-==[[Pneumonia differential diagnosis|Differentiating Pneumonia from other Diseases]]==
+==[[Community-acquired pneumonia historical perspective|Historical Perspective]]==
-==[[Pneumonia physical examination|Physical Examination]]==
+==[[Community-acquired pneumonia classification|Classification]]==
-==Diagnosis==
+==[[Community-acquired pneumonia pathophysiology|Pathophysiology]]==
-==[[Pneumonia diagnostic criteria|Diagnostic criteria]]==
-== Treatment ==
+==[[Community-acquired pneumonia causes|Causes]]==
-===[[Pneumonia medical therapy|Medical Therapy]]===
-==[[Pneumonia prevention|Prevention]]==
+==[[Community-acquired pneumonia differential diagnosis|Differentiating Community-acquired pneumonia from other Diseases]]==
-==References==
+==[[Community-acquired pneumonia epidemiology and demographics|Epidemiology and Demographics]]==
-{{Reflist}}
-#{{note|Sharma}} [http://www.emedicine.com/med/topic1852.htm Emedicine review of bacterial pneumonia]
-#{{note|Metaly}} Metaly JP, Schulz R, Li Y-H, Singer DE, Marrie TJ, Coley CM, Hough LJ, Obrosky DS, Kapoor WN, Fine MJ. ''Influence of age on symptoms at presentation in patients with community-acquired pneumonia.'' Arch Intern Med 1997; 157: 1453-1459 PMID 9224224
-#{{note|Metlay}} Metlay, JP, Kapoor, WN, Fine, MJ. D''oes this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.'' JAMA 1997; 278:1440. PMID 9356004
-#{{note|Syrjala}} Syrjala H, Broas M, Suramo I, Ojala A, Lahde S. ''High resolution computed tomography for the diagnosis of community-acquired pneumonia.'' Clin Infect Dis 1998; 27: 358-363 PMID 9709887
-#{{note|Webber}} Webber, S, Wilkinson, AR, Lindsell, D, et al. ''Neonatal pneumonia.'' Arch Dis Child 1990; 65:207.PMID 2107797
-#{{note|Abzug}} Abzug, MJ, Beam, AC, Gyorkos, EA, Levin, MJ. ''Viral pneumonia in the first month of life.'' Pediatr Infect Dis J 1990; 9:881. PMID 2177540
-#{{note|Wubbel}} Wubbel, L, Muniz, L, Ahmed, A, et al. ''Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999; 18:98.'' PMID 10048679
-#{{note|Roux}} de Roux, A, Marcos, MA, Garcia, E, et al. ''Viral community-acquired pneumonia in nonimmunocompromised adults.'' Chest 2004; 125:1343.PMID 15078744
-#{{note|Ruhe}} Ruhe, JJ, Myers, L, Mushatt, D, Hasbun, R. ''High-level penicillin-nonsusceptible Streptococcus pneumoniae bacteremia: identification of a low-risk subgroup.'' Clin Infect Dis 2004; 38:508 PMID 14765343
-#{{note|Lieberman}} Lieberman D, Schlaeffer F, Boldur I, Lieberman D, Horowitz S, Friedman MG, Leiononen M, Horovitz O, Manor E, Porath A. ''Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.'' Thorax 1996; 51: 179-184 PMID 8711652
-#{{note|Bradley}} Bradley, JS. ''Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines.'' Pediatr Infect Dis J 2002; 21:592. PMID 12182396
-#{{note|Neiderman}} Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, et al. ''Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention.'' Am J Respir Crit Care Med 2001;163:1730–1754 PMID 11401897
-#{{note|Mundy}} Mundy, LM, Auwaerter, PG, Oldach, D, et al. ''Community-acquired pneumonia: impact of immune status.'' Am J Respir Crit Care Med 1995; 152:1309. PMID 7551387
-#{{note|Fine}} Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. ''A prediction rule to identify low-risk patients with community-acquired pneumonia.'' N Engl J Med 1997; 336: 243-250 PMID 8995086
-#{{note|Woodhead}} Woodhead MA, MacFarlane JT, McCracken JS, Rose DH, Finch RG. ''Prospective study of the aetiology and outcome of pneumonia in the community.'' Lancet 1987; i: 671-674. PMID 2882091
-#{{note|Garenne}} Garenne, M, Ronsmans, C, Campbell, H. ''The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries.'' World Health Stat Q 1992; 45:180. PMID 1462653
-#{{note|Almirall}} Almirall, J, Bolibar, I, Balanzo, X, Gonzalez, CA. ''Risk factors for community-acquired pneumonia in adults: A population-based case-control study.'' Eur Respir J 1999; 13:349. PMID 10065680
-#{{note|Butler}} Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. ''Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations.'' JAMA 1993; 270: 1826-1831. PMID 8411526
-#{{note|CDC}} Centers for Disease Control and Prevention. ''Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)''. MMWR 1999;48(RR-4):1-28.
-#{{note|Hayden}} Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. ''Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.'' N Engl J Med 1999; 341: 1336-1343 PMID 10536125
-==References==
-{{reflist|2}}
-[[Category:Diseaase]]
+==[[Community-acquired pneumonia risk factors|Risk Factors]]==
+==[[Community-acquired pneumonia screening|Screening]]==
+==[[Community-acquired pneumonia natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
+==Diagnosis==
+[[Community-acquired pneumonia severity criteria| Severity Criteria]] | [[Community-acquired pneumonia history and symptoms| History and Symptoms]] | [[Community-acquired pneumonia physical examination | Physical Examination]] | [[Community-acquired pneumonia laboratory findings |Laboratory Findings]] | [[Community-acquired pneumonia chest x ray|Chest X Ray]] | [[Community-acquired pneumonia CT|CT]] | [[Community-acquired pneumonia ultrasound|Ultrasound]] | [[Community-acquired pneumonia other diagnostic studies|Other Diagnostic Studies]]
+==Treatment==
+[[Community-acquired pneumonia medical therapy|Medical Therapy]] | [[Community-acquired pneumonia primary prevention|Primary Prevention]] | [[Community-acquired pneumonia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Community-acquired pneumonia future or investigational therapies|Future or Investigational Therapies]]
+==Case Studies==
+[[Community-acquired pneumonia case study one|Case #1]]
+[[Category:Disease]]
 [[Category:Pulmonology]]
-[[Category:Infectious disease]]
 [[Category:Pneumonia|Pneumonia]]
 [[Category:Emergency medicine]]
-{{WH}}
-{{WS}}

Community-acquired pneumonia: Difference between revisions

Latest revision as of 17:25, 30 November 2020

Diagnosis

Treatment

Case Studies

Navigation menu